Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following the Release of Safety Data

Documenti analoghi

• Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes
  di: Bryant R. England, et al.
  Pubblicazione: (2025)
• Adipokines and Associations With Incident Osteoporotic Fracture in Patients With Rheumatoid Arthritis
  di: Joshua F. Baker, et al.
  Pubblicazione: (2025)
• Agreement of Administrative Pharmacy Dispensing With Self‐Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis
  di: Beth I. Wallace, et al.
  Pubblicazione: (2025)
• Two Birds, One Stone: Lung Cancer Screening in Patients With Rheumatoid Arthritis Identifies Malignancy and Rheumatoid Arthritis–Associated Lung Disease
  di: Amir A. Razmjou, et al.
  Pubblicazione: (2026)
• Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas
  di: Anisha Naik, et al.
  Pubblicazione: (2024)